Figure 4 | Scientific Reports

Figure 4

From: Low-dose GBCA administration for brain tumour dynamic contrast enhanced MRI: a feasibility study

Figure 4

Kinetic parameter maps from a sporadic vestibular schwannoma patient imaged using the single, low GBCA dose interleaved HT-HS DCE-MRI protocol and full GBCA dose (FDHS) acquisition (A) Representative images from a patient with a large left sided sporadic VS imaged using the single-injection low-dose interleaved high-temporal and high-spatial resolution (HT-HS) DCE-MRI acquisition followed by a full dose high-spatial resolution (FDHS) acquisition. Kinetic maps derived using either the low-dose LEGATOSLDHS method or the full dose LEGATOSDICE method are shown. Note the increased vascularity around the tumour capsule, visible on both the high-spatial T2W DRIVE acquisition (voxel size = 0.5 × 0.5 × 0.5 × 0.5 mm3) and LEGATOS derived vp parameter maps ×. (B) Scatterplots demonstrating that for all parameters there was a significant voxelwise correlation between the LEGATOSLDHS and LEGATOSDICE derived values (p < 0.001) for the tumour shown in panel A. The overall median voxelwise difference (median % difference) for each of the LEGATOSLDHS derived parameters with respect to LEGATOSDICE estimates was− 0.01 (2.26%),− 0.10 min−1 (− 39.2%) and− 0.02 (− 30.0%) for ve, Ktrans and vp, respectively. For all parameters, the difference/bias in voxelwise LEGATOSLDHS estimates increased with increasing voxel values (p < 0.001) with regions of high Ktrans and vp on the LEGATOSDICE maps showing correspondingly lower LEGATOSLDHS derived parameter values.

Back to article page